Evaluation of Nociceptive Flexor Reflex Response in Patients with Painful Idiopathic Parkinson's Disease

Öz

Aim: We aimed to investigate the utility of trigeminocervical reflex (TCR) and nociceptive flexion reflex (NFR) as objective measures for assessing pain—a common NMS—in patients with PD, targeting both the upper and lower body regions. Methods: All subjects were further classified into four groups: Group-I: Healthy individuals without PD or pain, Group-II: Individuals without PD but reporting non-specific musculoskeletal pain, Group-III: PD patients without pain, Group-IV: PD patients with pain as a NMS. The clinical assessment of PD was conducted using the Hoehn and Yahr Staging Scale (HYS) and the Unified Parkinson's Disease Rating Scale (UPDR). We divided the human body into upper and lower regions—utilizing the TCR for upper body pain and the NFR for pain around the lumbar and pelvic areas. Results: The Group-IV had a longer mean disease duration than those in Group-III (8.0±6.6 vs 3.0±3.5 and p=0.121). The mean UPDRS score significantly higher in Group-IV compared to Group-III (42.5±13 vs 27.4±15.3 and p=0.022). The mean VAS score was 7.0±0.7 in Group-II and 6.3±1.3 in Group-IV, with no significant differences in pain localization or VAS scores between the two-groups. Conclusion: Electrophysiological reflex assessments do not appear to be sufficiently reliable in evaluating pain perception in these patients.

Anahtar Kelimeler

• Parkinson’s disease
• Pain
• Nociceptive flexion reflex

Destekleyen Kurum

None.

Etik Beyan

The study received approval from the Istanbul Universty Ethics Committee.

Teşekkür

None.

Ağrılı İdiyopatik Parkinson Hastalığı Olan Hastalarda Nosiseptif Fleksör Refleks Tepkisinin Değerlendirilmesi

Öz

Amaç: Parkinson hastalığı (PH) hastalarında, yaygın bir NMS olan ağrıyı değerlendirmede, hem üst hem de alt vücut bölgelerini hedef alan objektif ölçümler olarak trigeminoservikal refleks (TCR) ve nosiseptif fleksiyon refleksinin (NFR) kullanılabilirliğini araştırmayı amaçladık. Metot: Tüm denekler dört gruba ayrıldı: Grup I: PH veya ağrısı olmayan sağlıklı bireyler, Grup II: PH olmayan ancak spesifik olmayan kas-iskelet sistemi ağrısı bildiren bireyler, Grup III: Ağrısı olmayan PH hastaları, Grup IV: NMS olarak ağrısı olan PH hastaları. PH'nin klinik değerlendirmesi Hoehn ve Yahr Evreleme Ölçeği (HYS) ve Birleşik Parkinson Hastalığı Derecelendirme Ölçeği (UPDR) kullanılarak yapıldı. İnsan vücudunu üst ve alt bölgelere ayırdık; üst vücut ağrısı için TCR'yi, bel ve pelvik bölgelerdeki ağrı için ise NFR'yi kullandık. Sonuçlar: Grup IV'teki hastaların ortalama hastalık süresi Grup III'teki hastalardan daha uzundu (8,0±6,6'ya karşı 3,0±3,5 ve p=0,121). Ortalama UPDRS skoru Grup IV'te Grup III'e kıyasla anlamlı derecede yüksekti (42,5±13'e karşı 27,4±15,3 ve p=0,022). Ortalama VAS skoru Grup II'de 7,0±0,7, Grup IV'te ise 6,3±1,3 idi ve iki grup arasında ağrı lokalizasyonu veya VAS skorları arasında anlamlı bir fark yoktu. Sonuç: Elektrofizyolojik refleks değerlendirmeleri, bu hastalarda ağrı algısını değerlendirmede yeterince güvenilir görünmemektedir.

Anahtar Kelimeler

• Parkinson hastalığı
• Ağrı
• Nosiseptif fleksiyon refleksi

Destekleyen Kurum

Yok

Etik Beyan

Çalışma için İstanbul Üniversitesi Etik Kurulu’ndan onay alındı.

Teşekkür

Yok

Kaynakça

1. 1.de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 Jun;5(6):525-35. [Crossref]
2. 2.Poewe W. Treatments for Parkinson disease--past achievements and current clinical needs. Neurology. 2009 Feb 17;72(7 Suppl):S65-73. [Crossref]
3. 3.GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017 Nov;16(11):877-897. [Crossref]
4. 4.Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76. [Crossref]
5. 5.Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006 Mar;5(3):235-45. [Crossref]
6. 6.Stoyanova-Piroth G, Milanov I, Stambolieva K. Association between pain threshold and manifested pain assessed using a PD-specific pain scale in Parkinson's disease. Front Neurol. 2024 Jul 25;15:1420696. [Crossref]
7. 7.Grigoriou S, Martínez-Martín P, Ray Chaudhuri K, Rukavina K, Leta V, Hausbrand D, Falkenburger B, Odin P, Reichmann H. Effects of safinamide on pain in patients with fluctuating Parkinson's disease. Brain Behav. 2021 Oct;11(10):e2336. [Crossref]
8. 8.Tinazzi M, Recchia S, Simonetto S, Tamburin S, Defazio G, Fiaschi A, Moretto G, Valeriani M. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials. Mov Disord. 2010 Jan 30;25(2):213-20. [Crossref]

9. 9.Barboza VR, Kubota GT, da Silva VA, Barbosa LM, Arnaut D, Rodrigues ALL, Galhardoni R, Cury RG, Barbosa ER, Brunoni AR, Teixeira MJ, de Andrade DC. Parkinson's Disease-related Pains are Not Equal: Clinical, Somatosensory and Cortical Excitability Findings in Individuals With Nociceptive Pain. J Pain. 2023 Dec;24(12):2186-2198. [Crossref]
10. 10.Mylius V, Baars JH, Witt K, Benninger D, de Andrade DC, Kägi G, Bally JF, Brugger F. Deep Brain Stimulation Improves Parkinson's Disease-Associated Pain by Decreasing Spinal Nociception. Mov Disord. 2024 Feb;39(2):447-449. [Crossref]
11. 11.Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res. 2008 Jun;31(2):165-9. [Crossref]
12. 12.Fahn S, Elton RS, members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds). Recent Developments in Parkinson’s disease. NJ: Macmillan, Florham Park, 1987;153-63.
13. 13.Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 2001 Nov;57(10 Suppl 3):S11-26.
14. 14.French DJ, France CR, France JL, Arnott LF. The influence of acute anxiety on assessment of nociceptive flexion reflex thresholds in healthy young adults. Pain. 2005 Apr;114(3):358-363. [Crossref]
15. 15.Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain. 2009 Jan;141(1-2):173-7. [Crossref]
16. 16.Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012 Apr;27(4):480-4. [Crossref]
17. 17.Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010 Apr 30;25(6):704-9. [Crossref]
18. 18.Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O. Pain in Parkinson's disease: facts and uncertainties. Eur J Neurol. 2018 Jul;25(7):917-e69. [Crossref]
19. 19.Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández-de-Las-Peñas C. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013 Mar;19(3):285-94; discussion 285. [Crossref]
20. 20.Defazio G, Tinazzi M, Berardelli A. How pain arises in Parkinson's disease? Eur J Neurol. 2013 Dec;20(12):1517-23. [Crossref]
21. 21.Mostofi A, Morgante F, Edwards MJ, Brown P, Pereira EAC. Pain in Parkinson's disease and the role of the subthalamic nucleus. Brain. 2021 Jun 22;144(5):1342-1350. [Crossref]
22. 22.de Willer JC. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain. 1977 Feb;3(1):69-80. [Crossref]
23. 23.Kugelberg E, Eklund K, Grimby L. An electromyographic study of the nociceptive reflexes of the lower limb. Mechanism of the plantar responses. Brain. 1960 Sep;83:394-410. [Crossref]
24. 24.Meinck HM, Piesiur-Strehlow B, Koehler W. Some principles of flexor reflex generation in human leg muscles. Electroencephalogr Clin Neurophysiol. 1981 Aug;52(2):140-50. [Crossref]
25. 25.Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, Brefel-Courbon C. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1140-2. [Crossref]
26. 26.Mylius V, Baars JH, Witt K, Benninger D, de Andrade DC, Kägi G, Bally JF, Brugger F. Deep Brain Stimulation Improves Parkinson's Disease-Associated Pain by Decreasing Spinal Nociception. Mov Disord. 2024 Feb;39(2):447-449. [Crossref]
27. 27.Di Lazzaro V, Restuccia D, Nardone R, Tartaglione T, Quartarone A, Tonali P, Rothwell JC. Preliminary clinical observations on a new trigeminal reflex: the trigemino-cervical reflex. Neurology. 1996 Feb;46(2):479-85. [Crossref]
28. 28.Milanov I, Bogdanova D, Ishpekova B. The trigemino-cervical reflex in normal subjects. Funct Neurol. 2001 Apr-Jun;16(2):129-34.
29. 29.Di Lazzaro V, Guney F, Akpinar Z, Yürüten B, Oliviero A, Pilato F, Saturno E, Dileone M, Tonali PA, Rothwell JC. Trigemino-cervical reflexes: clinical applications and neuroradiological correlations. Suppl Clin Neurophysiol. 2006;58:110-9. [Crossref]
30. 30.Serrao M, Rossi P, Parisi L, Perrotta A, Bartolo M, Cardinali P, Amabile G, Pierelli F. Trigemino-cervical-spinal reflexes in humans. Clin Neurophysiol. 2003 Sep;114(9):1697-703. [Crossref]
31. 31.Bartolo M, Serrao M, Perrotta A, Tassorelli C, Sandrini G, Pierelli F. Lack of trigemino-cervical reflexes in progressive supranuclear palsy. Mov Disord. 2008 Jul 30;23(10):1475-9. [Crossref]